Justin F. Gainor

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Papers

Driven by 45 papers — median percentile 0. Top paper: “Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study”.

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

The Lancet Diabetes & Endocrinology(2021)10.1016/s2213-8587(21)00120-0

N/A

5.1DataRank · unranked

354 citations

Mimi I. Hu, Lori J. Wirth, Martin Schüler, Aaron S. Mansfield, Giuseppe Curigliano +20 more

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00247-3

N/A

5.0DataRank · unranked

445 citations

Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik +20 more

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0800

N/A

3.5DataRank · unranked

140 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Thyroid(2023)10.1089/thy.2023.0363

N/A

1.2DataRank · unranked

55 citations

Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schüler, Viola W. Zhu +19 more

Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

Journal of Thoracic Oncology(2015)10.1097/jto.0000000000000455

N/A

0.769DataRank · unranked

168 citations

Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth Kennedy, Priscilla K. Brastianos +3 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0.769DataRank · unranked

168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.15.557794

N/A

0.607DataRank · unranked

12 citations

Daniel A. Zlotoff, Neal P. Smith, Isabela Kernin, Swetha Ramesh, Leyre Zubiri +31 more

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

Nature Communications(2025)10.1038/s41467-025-61823-w

N/A

0.312DataRank · unranked

7 citations

Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky +32 more

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004440

N/A

0DataRank · unranked

125 citations

Venkata Nagineni, Arvind Ravi, Ila Datar, Mari Mino–Kenudson, Germán Corredor +11 more

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4256

N/A

0DataRank · unranked

98 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

The Journal of Experimental Medicine(2022)10.1084/jem.20212169

N/A

0DataRank · unranked

49 citations

Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia +21 more

Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.06.008

N/A

0DataRank · unranked

47 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +12 more

Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0976

N/A

0DataRank · unranked

46 citations

Christopher Alvarez‐Breckenridge, Justin F. Gainor, Priscilla K. Brastianos, Matthew R. Strickland

High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities

Cancer Research(2022)10.1158/0008-5472.can-22-0432

N/A

0DataRank · unranked

36 citations

Yifat Geffen, Hongui Cha, Mendy Miller, Shankara Anand, Jaegil Kim +8 more

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients

Cancer Medicine(2022)10.1002/cam4.4808

N/A

0DataRank · unranked

15 citations

Yi Li, Robert S. Brown, Michael Lanuti, Justin F. Gainor, David C. Christiani +1 more

Phase II Study of Cabozantinib in Patients With Bone Metastasis

The Oncologist(2022)10.1093/oncolo/oyac083

N/A

0DataRank · unranked

9 citations

Gregory A. Coté, M. Dror Michaelson, Lori J. Wirth, Justin F. Gainor, Alona Muzikansky +6 more

Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9080

N/A

0DataRank · unranked

3 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +11 more

High-resolution lung adenocarcinoma expression subtypes identify tumors with dependencies on MET, CDK4, CDK6 , and PD-L1

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.20.481157

N/A

0DataRank · unranked

0 citations

Yifat Geffen, Mendy Miller, Shankara Anand, Jaegil Kim, David I. Heiman +5 more

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Nature(2023)10.1038/s41586-023-06303-1

N/A

0DataRank · unranked

148 citations

Ramin Sakhtemani, Ammal Abbasi, Naveed Nikpour, Marcello Stanzione, Sunwoo Oh +36 more

TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state

Cell Reports(2023)10.1016/j.celrep.2023.112129

N/A

0DataRank · unranked

58 citations

Ajinkya Revandkar, Taronish D. Dubash, Arvind Ravi, Ben S. Wittner, Maoxuan Lin +14 more

Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2457

N/A

0DataRank · unranked

14 citations

Yvonne Wang, Gang Peng, Jianlei Gu, Mari Mino–Kenudson, Jonathan W. Riess +6 more

Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0419

N/A

0DataRank · unranked

68 citations

Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J. Plodkowski, Mustafa Sakhi +11 more

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution

npj Precision Oncology(2023)10.1038/s41698-023-00464-y

N/A

0DataRank · unranked

8 citations

Khvaramze Shaverdashvili, Mari Mino–Kenudson, Subba R. Digumarthy, Andrew Do, Audrey Liu +5 more

Data from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.c.6530655.v1

N/A

0DataRank · unranked

0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Data from High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities

(2023)10.1158/0008-5472.c.6514175

N/A

0DataRank · unranked

0 citations

Yifat Geffen, Hongui Cha, Mendy Miller, Shankara Anand, Jaegil Kim +8 more

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

Nature Immunology(2024)10.1038/s41590-024-01792-2

N/A

0DataRank · unranked

132 citations

Linda T. Nieman, Maxwell Spurrell, Vjola Jorgji, Liad Elmelech, Peter Richieri +32 more

Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20231106

N/A

0DataRank · unranked

24 citations

Katherine Hastings, Jungmin Choi, Isabelle Sirois, Arvind Ravi, Francisco Expósito +14 more

Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer

Journal of Cachexia Sarcopenia and Muscle(2024)10.1002/jcsm.13469

N/A

0DataRank · unranked

23 citations

Tianqi Ouyang, Ismail Tahir, Nurit Katz‐Agranov, Qiyu Wang, Lea Mantz +13 more

Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis

ESMO Open(2024)10.1016/j.esmoop.2024.103660

N/A

0DataRank · unranked

11 citations

B.Y. Yeap, Justin F. Gainor, Zofia Piotrowska

Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study

Lung Cancer(2024)10.1016/j.lungcan.2024.108003

N/A

0DataRank · unranked

8 citations

Alissa J. Cooper, Bruce E. Johnson, Justin F. Gainor, W. Marston Linehan, Lecia V. Sequist +6 more

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100645

N/A

0DataRank · unranked

4 citations

Jiyoon Kang, Beow Y. Yeap, Jennifer Peterson, Andrew Do, Justin F. Gainor +3 more

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Annals of Oncology(2025)10.1016/j.annonc.2025.01.020

N/A

0DataRank · unranked

51 citations

Ferran Fece de la Cruz, W. Marston Linehan, Christine M. Parseghian, Jonathan Kim, Hiroyuki Matsubara +19 more

Oxidation of retromer complex controls mitochondrial translation

Nature(2025)10.1038/s41586-025-08756-y

N/A

0DataRank · unranked

28 citations

Md Yousuf Ali, Harrison B. Chong, Pei-Chieh Tien, James Woods, Carolina Noble +30 more

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100534

N/A

0DataRank · unranked

13 citations

Lesli A. Kiedrowski, Rebecca S. Heist, W. Marston Linehan, Catherine B. Meador, Elizabeth Krueger +7 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Resistance to lorlatinib in ROS1 fusion-positive non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9611

N/A

0DataRank · unranked

20 citations

Ted W. Johnson, Jochen K. Lennerz, Charlotte Lee, Harper Hubbeling, Beow Y. Yeap +4 more

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0365

N/A

0DataRank · unranked

520 citations

W. Marston Linehan, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski +15 more

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.10.013

N/A

0DataRank · unranked

374 citations

Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong +28 more

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology(2021)10.1038/s41571-021-00487-z

N/A

0DataRank · unranked

140 citations

Justin F. Gainor, Aparna Hegde, Alison M. Schram, Giuseppe Curigliano, Sumanta K. Pal +19 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

0DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

Structural and functional analysis of lorlatinib analogs reveals roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.16.452681

N/A

0DataRank · unranked

2 citations

Ted W. Johnson, Ibiayi Dagogo‐Jack, Mari Mino–Kenudson, Theodore R. Johnson, Ping Wei +16 more

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Annals of Oncology(2022)10.1016/j.annonc.2022.08.002

N/A

0DataRank · unranked

181 citations

Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more

Justin F. Gainor

Indexed papers

Top data-sharing exemplar

Papers